CNS Pharmaceuticals, Inc. (CNSP) Balance Sheet
CNSP balance sheet, 2025
December 31, 2025 · U.S. dollars$8.6M assets = $4.1M liabilities + $4.5M equity
Both columns are drawn to the same scale: what CNSP owns equals what it owes plus shareholders’ equity. Hover a block for its value.
CNSP financial health
Descriptive bands, not a rating. Fiscal 2025.
CNSP balance sheet trends, 2017–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $162,1942017 | $8.6M2025 | +64.3%/yr | |
| Total liabilities | $220,7262017 | $4.1M2025 | +44.1%/yr | |
| Shareholders’ equity | −$58,5322017 | $4.5M2025 | — | |
| Cash & short-term investments | $110,5432017 | $7.2M2025 | +68.6%/yr | |
| Total debt | $121,8252017 | $328,5712025 | +13.2%/yr | |
| Net cash (debt) | −$11,2822017 | $6.9M2025 | +$6.9M | |
| Working capital | −$58,5322017 | $4.0M2025 | +$4.1M | |
| Current ratio | 0.732017 | 1.982025 | +1.24 | |
| Debt / equity | 0.032020 | 0.072025 | +0.04 |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
CNSP assets
CNSP liabilities and equity
CNSP debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
CNSP balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & short-term investments | $7.2M | $6.5M | $548,721 | $10.1M | $5.0M | $14.0M | $7.2M | $282,736 | $110,543 |
| Cash & equivalents | $7.2M | $6.5M | $548,721 | $10.1M | $5.0M | $14.0M | $7.2M | $282,736 | $110,543 |
| Receivables | $0 | $882,539 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $901,787 | $1.3M | $1.0M | $2.5M | $2.5M | $1.5M | $652,622 | $305,397 | $51,651 |
| Total current assets | $8.1M | $8.7M | $1.6M | $12.6M | $7.5M | $15.5M | $7.9M | $588,133 | $162,194 |
| Property, plant & equipment (net) | $17,703 | $6,005 | $4,933 | $5,664 | $16,109 | $23,431 | $18,165 | $0 | $0 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $334,138 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $502,962 | $36,430 | $104,750 | $482,806 | $1.3M | $0 | $0 | $95,200 | $0 |
| Total assets | $8.6M | $8.7M | $1.7M | $13.1M | $8.8M | $15.9M | $7.9M | $683,333 | $162,194 |
| Liabilities | |||||||||
| Accounts payable | $3.8M | $2.2M | $5.8M | $3.7M | $1.5M | $946,330 | $289,499 | $128,865 | $57,497 |
| Short-term debt | $328,571 | $326,072 | $300,806 | $409,968 | $387,794 | $439,294 | — | $316,918 | $121,825 |
| Deferred revenue | — | — | −$5.8M | — | — | — | — | $23,599 | — |
| Total current liabilities | $4.1M | $2.5M | $6.1M | $4.9M | $2.1M | $1.9M | $311,000 | $1.2M | $220,726 |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $0 | $0 | $0 | $4.1M | $1.9M | $1.4M | $289,499 | $445,783 | $179,322 |
| Total liabilities | $4.1M | $2.5M | $6.1M | $4.9M | $2.1M | $1.9M | $311,000 | $1.2M | $220,726 |
| Shareholders' equity | |||||||||
| Common stock & paid-in capital | $633 | $1,414 | $6,214 | $1,617 | $27,927 | $23,856 | $16,450 | $12,695 | $10,271 |
| Retained earnings (deficit) | −$100.3M | −$84.4M | −$69.6M | −$50.7M | −$35.0M | −$20.9M | −$11.5M | −$7.6M | −$219,362 |
| Accumulated other comprehensive income | — | — | — | — | — | $0 | $0 | — | — |
| Total shareholders' equity | $4.5M | $6.2M | −$4.4M | $8.1M | $6.6M | $13.9M | $7.6M | −$549,298 | −$58,532 |
| Key figures | |||||||||
| Total debt | $328,571 | $326,072 | $300,806 | $409,968 | $387,794 | $439,294 | — | $316,918 | $121,825 |
| Net cash (debt) | $6.9M | $6.1M | $247,915 | $9.6M | $4.6M | $13.6M | — | −$34,182 | −$11,282 |
| Working capital | $4.0M | $6.1M | −$4.5M | $7.6M | $5.3M | $13.6M | $7.6M | −$644,498 | −$58,532 |
| Tangible book value | $4.5M | $6.2M | −$4.4M | $8.1M | $6.6M | $13.6M | $7.6M | −$549,298 | −$58,532 |
| Book value per share | $10.20 | — | — | — | — | — | — | — | — |
| Shares outstanding | 443K | — | — | — | — | — | — | — | — |
| Current ratio | 1.98 | 3.43 | 0.26 | 2.55 | 3.50 | 8.13 | 25.38 | 0.48 | 0.73 |
| Quick ratio | 1.76 | 2.91 | 0.09 | 2.04 | 2.34 | 7.37 | 23.28 | 0.23 | 0.50 |
| Debt / equity | 0.07 | 0.05 | — | 0.05 | 0.06 | 0.03 | — | — | — |
| Equity / assets | 52.4% | 71.0% | −260.6% | 62.3% | 75.6% | 88.0% | 96.1% | −80.4% | −36.1% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $20.0M | $3.0M | $7.2M | $9.9M | $12.1M | $13.0M | $6.5M | $7.0M | $1.5M | $815,226 | $548,721 | $909,547 |
| Cash & equivalents | $20.0M | $3.0M | $7.2M | $9.9M | $12.1M | $13.0M | $6.5M | $7.0M | $1.5M | $815,226 | $548,721 | $909,547 |
| Receivables | $0 | $0 | $0 | $0 | $0 | $882,539 | $882,539 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $1.9M | $1.1M | $901,787 | $1.5M | $2.0M | $0 | $1.3M | $414,974 | $653,837 | $786,050 | $1.0M | $1.2M |
| Total current assets | $21.9M | $4.1M | $8.1M | $11.4M | $14.1M | $13.7M | $8.7M | $7.4M | $2.1M | $1.6M | $1.6M | $2.1M |
| Property, plant & equipment (net) | $15,000 | $22,014 | $17,703 | $3,107 | $3,804 | $4,905 | $6,005 | $2,802 | $3,553 | $4,305 | $4,933 | $3,470 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $580,087 | $502,962 | $474,416 | $366,251 | $22,384 | $36,430 | $18,373 | $320,320 | $55,296 | $104,750 | $262,731 |
| Total assets | $21.9M | $4.7M | $8.6M | $11.9M | $14.5M | $13.7M | $8.7M | $7.4M | $2.5M | $1.7M | $1.7M | $2.3M |
| Liabilities | ||||||||||||
| Accounts payable | $3.7M | $4.4M | $3.8M | $1.9M | $1.3M | $2.6M | $2.2M | $4.0M | $6.6M | $5.9M | — | $4.0M |
| Short-term debt | — | $232,353 | $328,571 | $30,793 | $121,767 | $210,673 | $326,072 | $31,187 | $123,248 | $213,104 | — | $41,904 |
| Deferred revenue | — | — | — | — | — | — | — | — | −$6.6M | −$5.9M | — | −$4.0M |
| Total current liabilities | $3.7M | $4.6M | $4.1M | $2.0M | $1.4M | $2.8M | $2.5M | $4.1M | $6.8M | $6.1M | $6.1M | $4.1M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total liabilities | $3.7M | $4.6M | $4.1M | $2.0M | $1.4M | $2.8M | $2.5M | $4.1M | $6.8M | $6.1M | $6.1M | $4.1M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $2,000 | $811 | $633 | $574 | $504 | $2,945 | $1,414 | $33,446 | $1,443 | $10,669 | — | $4,207 |
| Retained earnings (deficit) | −$107.8M | −$105.2M | −$100.3M | −$94.3M | −$91.1M | −$88.7M | −$84.4M | −$81.2M | −$75.6M | −$73.1M | −$69.6M | −$64.2M |
| Total shareholders' equity | $18.2M | $70,705 | $4.5M | $9.9M | $13.1M | $11.0M | $6.2M | $3.4M | −$4.3M | −$4.4M | −$4.4M | −$1.7M |
| Key figures | ||||||||||||
| Total debt | — | $232,353 | $328,571 | $30,793 | $121,767 | $210,673 | $326,072 | $31,187 | $123,248 | $213,104 | — | $41,904 |
| Net cash (debt) | — | $2.7M | $6.9M | $9.8M | $12.0M | $12.8M | $6.1M | $6.9M | $1.4M | $602,122 | — | $867,643 |
| Working capital | $18.2M | −$531,396 | $4.0M | $9.4M | $12.8M | $10.9M | $6.1M | $3.3M | −$4.6M | −$4.5M | −$4.5M | −$2.0M |
| Tangible book value | $18.2M | $70,705 | $4.5M | $9.9M | $13.1M | $11.0M | $6.2M | $3.4M | −$4.3M | −$4.4M | −$4.4M | −$1.7M |
| Book value per share | $2.66 | $0.10 | $10.20 | $17.73 | $35.46 | — | — | — | — | — | — | — |
| Shares outstanding | 6.8M | 676K | 443K | 559K | 370K | — | — | — | — | — | — | — |
| Current ratio | 5.86 | 0.88 | 1.98 | 5.81 | 10.22 | 4.94 | 3.43 | 1.82 | 0.32 | 0.26 | 0.26 | 0.51 |
| Quick ratio | 5.35 | 0.64 | 1.76 | 5.03 | 8.77 | 5.01 | 2.91 | 1.72 | 0.22 | 0.13 | 0.09 | 0.22 |
| Debt / equity | — | 3.29 | 0.07 | 0.00 | 0.01 | 0.02 | 0.05 | 0.01 | — | — | — | — |
| Equity / assets | 83.0% | 1.5% | 52.4% | 83.5% | 90.5% | 79.8% | 71.0% | 45.2% | −173.9% | −266.8% | −260.6% | −74.8% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 31, 2026); data from EODHD.
CNSP financial position
At the end of fiscal 2025 (December 31, 2025), CNS Pharmaceuticals had total assets of $8.6 million (down 0.9% from a year earlier), total liabilities of $4.1 million and shareholders' equity of $4.5 million. It held $7.2 million in cash and short-term investments against $0.3 million of debt, a net cash position of $6.9 million. Its current ratio was 1.98. In the latest quarter (ended June 30, 2026) total assets were $21.9 million and equity $18.2 million.
Related: CNSP income statement, CNSP cash flow statement, CNSP key metrics. See the CNSP stock overview for the latest quote and news.
CNSP balance sheet FAQ
What are CNS Pharmaceuticals's total assets?
CNS Pharmaceuticals reported total assets of $8.6 million at the end of fiscal 2025 (December 31, 2025), compared with $8.7 million a year earlier.
How much debt does CNS Pharmaceuticals have?
CNS Pharmaceuticals had $0.3 million of total debt at the end of fiscal 2025, including short-term borrowings. Its debt-to-equity ratio was 0.07.
How much cash does CNS Pharmaceuticals have?
CNS Pharmaceuticals held $7.2 million in cash and short-term investments at the end of fiscal 2025; with $0.3 million of debt that is net cash of $6.9 million.
What is CNS Pharmaceuticals's book value?
CNS Pharmaceuticals's shareholders' equity (book value) was $4.5 million at the end of fiscal 2025, or $10.20 per share.
What is CNS Pharmaceuticals's current ratio?
CNS Pharmaceuticals had current assets of $8.1 million and current liabilities of $4.1 million, a current ratio of 1.98 (it can cover its short-term obligations).